Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

IDEVvsIDNA

iShares Core MSCI International Developed Markets ETF against iShares Genomics Immunology and Healthcare ETF — the fee, the flows, the book, and a year head-to-head.

One year, growth of $100
IDEV 110IDNA 150Nov 25Nov 26GROWTH OF $100
Head to head
IDEVIDNA
Expense ratio0.040%0.47%
Assets$34B$340M
Net flow, 1 month+$587M+$36M
Net flow, 1 year+$8B+$138M
Return, YTD+7.2%+49.9%
Return, 1 year——
Avg daily volume2.2M163K
Holdings231050
ListedMar 21, 2017Jun 11, 2019
Options marketYesYes

MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.